Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Primary Peritoneal Carcinoma
Related studies linked through entity extraction aliases.
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care
- Status
- WITHDRAWN
- Phase
- NA
National Cancer Institute "Cancer Moonshot Biobank"
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
- Status
- COMPLETED
- Phase
- N/A
A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- PHASE3
Phase I Trial HIPEC With Nal-irinotecan
- Status
- COMPLETED
- Phase
- PHASE1
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
- Status
- RECRUITING
- Phase
- PHASE2
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
- Status
- TERMINATED
- Phase
- PHASE2
European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
- Status
- COMPLETED
- Phase
- PHASE2
Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE1